French prosecutors launch criminal investigation into Philips ventilator recall Alnylam talks the walk in making case for Onpattro in rare heart disease GOP lawmakers throw cold water on White House's latest $26B COVID, monkeypox ask Oxford malaria vaccine maintains bite after booster; Researchers hope for shot approval in 2023 New Apple Watch adds dual body temperature sensors, FDA-cleared afib tracking With long-awaited FDA nod, Revance set to take on AbbVie's Botox with its longer-lasting Daxxify VistaGen gets green light to restart phase 3 trial for social anxiety spray despite past failure Morgan Health turns eye to home care with $20M investment in LetsGetChecked Here we go again: FDA opens up emergency authorizations to monkeypox tests Did NICE play fair? J&J wins appeal—in part—to glean rationale behind cost watchdog's Spravato snub ESMO: Mirati plays the hits, posting colorectal KRAS data that mirror results reported to fanfare last year Many nurses still eyeing an exit as pandemic frustrations persist, survey finds Featured Story | By Andrea Park The legal troubles continue for Philips and the seemingly never-ending recall of around 5.5 million of its breathing support machines. read more |
| |
|---|
|
Top Stories By Kevin Dunleavy For patients with the heart failure condition transthyretin-mediated amyloidosis with cardiomyopathy, Alnylam’s Onpattro may not increase your chances of living longer or of avoiding a cardio event. But it can improve your quality of life and that is what the company is emphasizing. read more By Dave Muoio More funds for the public health emergencies were chief among the "critical needs" the Office of Management and Budget highlighted for the government's coming fiscal quarter. read more By Gabrielle Masson An investigational malaria vaccine booster from the University of Oxford maintained high efficacy levels a year after the initial shots—a feat in a disease area that scientists have long struggled to develop effective vaccines and therapies. read more By Andrea Park Another crop of health-focused additions to Apple’s eponymous wearable device are ready for harvest. The tech giant unveiled the new features during a keynote presentation Wednesday, with the rollout slated to begin later this month. read more By Kevin Dunleavy The FDA has approved Revance’s long-awaited Botox competitor, Daxxify. The cosmetic treatment temporarily removes moderate to severe glabbelar (frown) lines, and its effects have been shown to last for six months versus three for Botox. read more By James Waldron VistaGen Therapeutics has been given the all-clear to continue a phase 3 trial of its social anxiety nose spray after the biotech paused enrollment following poor results from a similar late-stage study. read more By Paige Minemyer Morgan Health is making its latest strategic investment, this time with an eye on home health. read more By Conor Hale Using what was once a lesser-known regulatory option made world famous by the COVID-19 pandemic, the FDA has granted its first Emergency Use Authorization to a diagnostic test for monkeypox as cases continue to spread worldwide. read more By Fraiser Kansteiner An appeals panel has ruled NICE may have erred in its recent rejection of Janssen’s Spravato for treatment-resistant depression in the U.K. Janssen in June contested the watchdog’s rebuff of its ketamine-derivative nasal spray, which earned a U.S. nod in conjunction with oral antidepressants back in 2019. read more By Nick Paul Taylor Mirati Therapeutics has taken the lid off updated data on KRAS inhibitor adagrasib in colorectal cancer. Having established itself as the front-runner in the space last year, the biotech has presented a new look at the data that largely reaffirm the earlier findings. read more By Dave Muoio Similar responses from 2021 and 2022 surveys suggest “nothing has changed” for nurses facing burnout and aggravated by their employers' short-staffing. read more Resources Sponsored by: Genpact Learn how a private health insurance company uses analytics to deliver exceptional service to its employees and members Sponsored by: ReachBio | The Cell Biology Experts™ How can we predict the ability of a preclinical drug to inadvertently cause or intentionally inhibit cytokine secretion and T cell activation Sponsored by: DocuSign Today’s healthcare systems are adapting to an ever changing landscape with declining margins, M&A pressures, and the need for staff flexibility due to shortages. Read our whitepaper and dive into the way healthcare providers can digitally transform day-to-day work by streamlining costs and increasing agility by removing manual paper burdens. Sponsored by: Blue Matter, strategic consultants in the life sciences This paper explores how Medical Affairs is increasingly playing a key leadership role in evidence planning and generation (part 3 in a series). Sponsored by: Ferma.AI, a Product of ZoomRx Improve your congress competitive intelligence and cut down costs by 50% Sponsored by: Catalent Learn more about how the transition from early to late phase of a small molecule program plays a pivotal role in a program’s ultimate success. Sponsored by: Bio-Techne Advanced research requires advanced tools. Our next-generation ELISA takes a fraction of the time to run eight analytes simultaneously while saving your sample volume. Simply load, scan, and insert your cartridge and come back to fully analyzed results in 75 minutes. Rethink your ELISA, with Ella. Sponsored by: Thermo Fisher Scientific Set a solid foundation for successful scale-up of buffer preparation. Sponsored by: JLL Read through this library of resources to find out how you can strengthen innovation and efficiency, improve safety and quality, and prioritize resources to support your long-term goals. Sponsored by: Catalent What is the most suitable dosage form technology for the Oral Delivery of Lipid-Based Formulations? Sponsored by: Catalent Learn how formulation development for a PFS affects manufacturing to drive the industry toward optimizing delivery of injectable products and, ultimately, improving patient care. Sponsored by: Catalent What are key considerations for intranasal delivery in the treatment of acute and chronic conditions? Sponsored by: Catalent Learn more about how the versatility of Softgel Technology helped a customer with a volatile compound. Sponsored by: Catalent How can Lipid-Based Drug Delivery System help bring poorly soluble drugs to market? Sponsored by: Catalent Carla Vozone discusses the significant trends in the OINDP segment including large molecules and novel indications, changes within CDMOs and various challenges facing the industry. Sponsored by: Catalent Did you know Catalent has newly expanded in-house capabilities spanning clinical and commercial scale manufacturing for DPIs, unit-dose, bi-dose and preserved multi-dose nasal sprays? Sponsored by: Catalent Ypsomed and Catalent Biologics experts discuss strategies for integrated PFS manufacturing and auto-injector assembly to accelerate timelines and more in this webinar. | 